Preeclampsia and breast cancer: The influence of birth characteristics

Breast

Volumn 24, Issue 5, 2015, Pages 613-617

  Pacheco, Nadja Livia Pekkola ^a   Andersen, Anne Marie Nybo ^a   Kamper Jørgensen, Mads ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast cancer; Denmark; Epidemiology; Preeclampsia; Pregnancy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CHILDBIRTH; COHORT ANALYSIS; DANISH CITIZEN; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; RISK REDUCTION; WOMEN'S HEALTH; BREAST NEOPLASMS; DENMARK; INCIDENCE; MALE; NEWBORN; PARITY; PRE-ECLAMPSIA; PREGNANCY; PROTECTION; REGISTER; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TERM BIRTH; YOUNG ADULT;

ADULT; BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; PARITY; PRE-ECLAMPSIA; PREGNANCY; PROTECTIVE FACTORS; REGISTRIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TERM BIRTH; YOUNG ADULT;

EID: 84952639707     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2015.06.006     Document Type: Article

References (40)

1. Steegers E.A., von D.P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet 2010, 376(9741):631-644.
2. Hernandez-Diaz S., Toh S., Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 2009, 338:b2255.
3. Khan K.S., Wojdyla D., Say L., Gulmezoglu A.M., Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-1074.
4. Trogstad L., Magnus P., Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 2011, 25(3):329-342.
5. Kim J.S., Kang E.J., Woo O.H., Park K.H., Woo S.U., Yang D.S., et al. The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis. Acta Oncol 2013, 52(8):1643-1648.
6. Vatten L.J., Forman M.R., Nilsen T.I., Barrett J.C., Romundstad P.R. The negative association between pre-eclampsia and breast cancer risk may depend on the offspring's gender. Br J Cancer 2007, 96(9):1436-1438.
7. Knudsen L.B., Olsen J. The Danish medical birth registry. Dan Med Bull 1998, 45(3):320-323.
8. Alexander G.R., Himes J.H., Kaufman R.B., Mor J., Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996, 87(2):163-168.
9. Lynge E., Sandegaard J.L., Rebolj M. The Danish national patient register. Scand J Public Health 2011, 39(7 Suppl):30-33.
10. International classification of diseases. WHO collaborating centers. Epidemiol Bull 1998, 19(3):7-11.
11. Pedersen C.B. The Danish civil registration system. Scand J Public Health 2011, 39(7 Suppl):22-25.
12. Gjerstorff M.L. The Danish cancer registry. Scand J Public Health 2011, 39(7 Suppl):42-45.
13. SAS Institute Inc SAS/STAT software release 9.3 2008, SAS Institute Inc, Cary, NC.
14. Rostgaard K. Methods for stratification of person-time and events - a prerequisite for poisson regression and SIR estimation. Epidemiol Perspect Innov 2008, 5:7.
15. Calderon-Margalit R., Friedlander Y., Yanetz R., Deutsch L., Perrin M.C., Kleinhaus K., et al. Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 2009, 200(1):63-65.
16. Talamini R., Franceschi S., Favero A., Negri E., Parazzini F., La V.C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997, 75(11):1699-1703.
17. Innes K.E., Byers T.E. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004, 112(2):306-311.
18. Ma H., Henderson K.D., Sullivan-Halley J., Duan L., Marshall S.F., Ursin G., et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California teachers study cohort. Breast Cancer Res 2010, 12(3):R35.
19. Opdahl S., Romundstad P.R., Alsaker M.D., Vatten L.J. Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 2012, 107(1):176-182.
20. Polednak A.P., Janerich D.T. Characteristics of first pregnancy in relation to early breast cancer. A case-control study. J Reprod Med 1983, 28(5):314-318.
21. Terry M.B., Perrin M., Salafia C.M., Zhang F.F., Neugut A.I., Teitelbaum S.L., et al. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 2007, 165(9):1007-1014.
22. Thompson W.D., Jacobson H.I., Negrini B., Janerich D.T. Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 1989, 81(20):1571-1574.
23. Troisi R., Weiss H.A., Hoover R.N., Potischman N., Swanson C.A., Brogan D.R., et al. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998, 9(6):641-647.
24. Troisi R., Innes K.E., Roberts J.M., Hoover R.N. Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role?. Br J Cancer 2007, 97(5):688-690.
25. Vatten L.J., Romundstad P.R., Trichopoulos D., Skjaerven R. Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002, 87(9):971-973.
26. Nechuta S., Paneth N., Velie E.M. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 2010, 21(7):967-989.
27. Innes K.E., Byers T.E. Preeclampsia and breast cancer risk. Epidemiology 1999, 10(6):722-732.
28. Waller D.K., Lustig L.S., Cunningham G.C., Feuchtbaum L.B., Hook E.B. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996, 88(5):816-822.
29. Troisi R., Potischman N., Roberts J.M., Ness R., Crombleholme W., Lykins D., et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003, 32(3):455-460.
30. Kleinrouweler C.E., Wiegerinck M.M., Ris-Stalpers C., Bossuyt P.M., van der Post J.A., von Dadelszen P., et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012, 119(7):778-787.
31. Gammill H.S., Aydelotte T.M., Guthrie K.A., Nkwopara E.C., Nelson J.L. Cellular fetal microchimerism in preeclampsia. Hypertension 2013, 62(6):1062-1067.
32. Kamper-Jørgensen M., Biggar R.J., Tjønneland A., Hjalgrim H., Kroman N., Rostgaard K., et al. Opposite effects of microchimerism on breast and colon cancer. Eur J Cancer 2012, 48:2227-2235.
33. Gadi V.K., Malone K.E., Guthrie K.A., Porter P.L., Nelson J.L. Case-control study of fetal microchimerism and breast cancer. PLoS One 2008, 3(3):e1706.
34. Gadi V.K. Fetal microchimerism and cancer. Cancer Lett 2009, 276(1):8-13.
35. Vatten L.J., Romundstad P.R., Trichopoulos D., Skjaerven R. Pregnancy related protection against breast cancer depends on length of gestation. Br J Cancer 2002, 87(3):289-290.
36. Mogren I., Stenlund H., Hogberg U. Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 2001, 40(7):849-854.
37. Vatten L.J., Skjaerven R. Offspring sex and pregnancy outcome by length of gestation. Early Hum Dev 2004, 76(1):47-54.
38. Wohlfahrt J., Melbye M. Maternal risk of breast cancer and birth characteristics of offspring by time since birth. Epidemiology 1999, 10(4):441-444.
39. Zhong X.Y., Holzgreve W., Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002, 21(1):77-83.
40. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003, 102(1):181-192.